{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:54:29Z","timestamp":1790952869073,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the long-term prognostic impact of atrial fibrillation and its subtypes in an unselected cohort undergoing coronary angiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial fibrillation is common in patients undergoing coronary angiography and linked to adverse outcomes, but the long-term prognostic impact of atrial fibrillation subtypes, particularly regarding heart failure risk, remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients undergoing coronary angiography from 2016 to 2022 were stratified by atrial fibrillation status and subtype (paroxysmal, persistent, permanent, new-onset). The primary endpoint was heart failure-related rehospitalization at 36 months. Secondary endpoints included coronary revascularization, acute myocardial infarction (AMI), and in-hospital all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 7529 patients, 26.8% had atrial fibrillation (i.e. paroxysmal: 37.7%; persistent: 14.8%, permanent: 16.6%, and new-onset atrial fibrillation: 31.0%). Compared with patients without atrial fibrillation, atrial fibrillation patients were older (median 76 vs. 67 years;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001) and had higher rates of heart failure, chronic kidney disease, and acute heart failure. At 36 months, heart failure\u2013related rehospitalization occurred more frequently in atrial fibrillation patients (30.2 vs. 18.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001), whereas AMI rates were similar, and coronary revascularization rates were lower. Atrial fibrillation was independently associated with heart failure\u2013related rehospitalization (hazard ratio\u2005=\u20051.246, 95% confidence interval: 1.108\u20131.400,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001), but not with coronary revascularization or AMI. H eart failure rehospitalization increased stepwise across atrial fibrillation subtypes, with the highest in permanent atrial fibrillation (42.5%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001) and progressively lower risk in persistent (34.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001), paroxysmal (26.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001), and new-onset atrial fibrillation (23.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Atrial fibrillation independently predicts long-term heart failure\u2013related rehospitalization after coronary angiography, highest in permanent followed by persistent atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001641","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:00:28Z","timestamp":1776153628000},"page":"518-527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term prognostic impact of atrial fibrillation subtypes in unselected patients undergoing coronary angiography"],"prefix":"10.1097","volume":"37","author":[{"given":"Henning Johann","family":"Steffen","sequence":"first","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schupp","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abumayyaleh","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Steinke","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Dudda","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielen","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Weidner","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Rusnak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Jannesari","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Center for Preventive Medicine and Digital Health (CPD), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Siegel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Center for Preventive Medicine and Digital Health (CPD), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[{"name":"Cardiology, Haemostasis, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial fibrillation: a review.","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes.","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation.","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"e24964","DOI":"10.1371\/journal.pone.0024964","article-title":"Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.","volume":"6","author":"Kralev","year":"2011","journal-title":"PLoS One"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.amjcard.2020.03.050","article-title":"Prognostic value of subclinical coronary artery disease in atrial fibrillation patients identified by coronary computed tomography angiography.","volume":"126","author":"Nous","year":"2020","journal-title":"Am J Cardiol"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jce.15351","article-title":"Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: a pooled analysis of data from 8 million patients.","volume":"33","author":"Noubiap","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2016.05.085","article-title":"Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention.","volume":"68","author":"Sutton","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41598-022-05688-9","article-title":"Long-term risk of adverse outcomes according to atrial fibrillation type.","volume":"12","author":"Blum","year":"2022","journal-title":"Sci Rep"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jacc.2017.09.027","article-title":"Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction.","volume":"70","author":"Mogensen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-023-02764-3","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.","volume":"21","author":"Fauchier","year":"2023","journal-title":"BMC Med"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/eurjpc\/zwae185","article-title":"Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.","volume":"31","author":"Schupp","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","article-title":"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.","volume":"39","author":"Zafrir","year":"2018","journal-title":"Eur Heart J"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ejhf.3402","article-title":"Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies.","volume":"27","author":"Valente","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjmed.2012.05.024","article-title":"Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.","volume":"125","author":"McManus","year":"2012","journal-title":"Am J Med"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"HAE0000000000000078","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association.","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure.","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2022.03.009","article-title":"Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.","volume":"251","author":"Aulin","year":"2022","journal-title":"Am Heart J"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2024.07.023","article-title":"Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis from COMBINE-AF.","volume":"84","author":"Haller","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/clinchem.2016.255182","article-title":"Application of biomarkers for risk stratification in patients with atrial fibrillation.","volume":"63","author":"Hijazi","year":"2017","journal-title":"Clin Chem"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/jce.15083","article-title":"Atrial fibrillation and atrial cardiomyopathies.","volume":"32","author":"Baman","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacc.2017.06.033","article-title":"Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad?","volume":"70","author":"Guichard","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.3390\/jcm14093250","article-title":"Atrial cardiomyopathy in atrial fibrillation: mechanistic pathways and emerging treatment concepts.","volume":"14","author":"Karakasis","year":"2025","journal-title":"J Clin Med"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/2047487316679265","article-title":"Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.","volume":"24","author":"Bayturan","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis.","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure.","volume":"406","author":"Khan","year":"2025","journal-title":"Lancet"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:44Z","timestamp":1790949644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001641","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}